Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice

Title
Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice
Authors
Keywords
Spinal cord, Neuropathic pain, Cytokines, Transcription factors, Cell membranes, Hyperalgesia, Spinal cord injury, Membrane proteins
Journal
PLoS One
Volume 10, Issue 4, Pages e0123122
Publisher
Public Library of Science (PLoS)
Online
2015-04-10
DOI
10.1371/journal.pone.0123122

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search